Amplifon stock gains 1.50 percent as GN Hearing deal advances

Amplifon stock gained 1.50 percent to EUR 11.82 on Euronext Milan on September 23, 2026, while the company's planned GN Hearing acquisition moved closer to its next corporate step. The transaction includes 56,000,000 new ordinary shares reserved for GN Store Nord, according to Amplifon.

GN Hearing adds a capital step

Amplifon's board resolved on September 17, 2026, to convene a shareholder meeting for the capital increase linked to GN Hearing. The planned issuance is designed to provide the share component of the acquisition consideration and would give GN a material position in Amplifon after completion.

The same board resolution also covers the proposed appointment of a GN representative to Amplifon's board and a partial demerger intended to make the group structure more efficient. That makes the transaction more than a single acquisition milestone: it combines financing, governance and corporate restructuring.

Synergies define the payoff

Il Sole 24 Ore reported on September 23, 2026, that BofA analysts saw the hearing aid market moving toward 3 percent growth, with stabilization in France and improving trends in Italy and Spain. The report also put potential net synergies from GN Hearing at EUR 60-80 million, mainly through higher internal sourcing by 2029.

The financing carries a measurable balance-sheet consequence. The net debt to EBITDA ratio is expected at 3.5 times at closing, with a planned reduction of 0.3 times per year, according to the same September 23 report. For investors, the integration pace and debt reduction now matter alongside the revenue opportunity.

Price stays below the yearly high

Amplifon was trading at EUR 11.82 on Euronext Milan on September 23, 2026, at 5:35 p.m. CEST, after a 1.50 percent daily gain. The EUR 2,600,526,005 market capitalization and the EUR 7.84 to EUR 15.84 52-week range show that the stock remains EUR 4.02 below its yearly high, leaving the acquisition execution as the central valuation test.